HKND YB1 Pharmaceutical LTD

The world's first oxygen-regulated live bacterial drug-delivery vector for cancer immunotherapy

  • Stage Full Product Ready
  • Industry Healthcare Services
  • Location Hongkong
  • Currency HKD
  • Founded January 2021
  • Employees 20
  • Incorporation Type Not Incorporated
  • Website yb1bio.com

Company Summary

In the future, HKND YB1 PHARMACEUTUCAL LIMITED will make an effort in tumor targeted therapy to accelerate YB1 human clinical trials and expand different.We will actively promote YB1 commercial application through the mode of innovative R&D-Global authorization, and make a contribution to the research and development of innovative drugs for fighting cancer and cancer treatment.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free